Niagen Bioscience (NAGE) Change in Inventory (2011 - 2026)

Niagen Bioscience (NAGE) has 14 years of Change in Inventory data on file, last reported at $3.6 million in Q1 2026.

• On a quarterly basis, Change in Inventory rose 79.28% year-over-year to $3.6 million in Q1 2026; TTM through Mar 2026 was $13.2 million, a 1108.78% increase from a year earlier, with the FY2025 full-year figure at $11.6 million, up 318.17% from the prior year.
• Change in Inventory for Q1 2026 stood at $3.6 million, up from $2.0 million in the prior quarter.
• Over the last five years, Change in Inventory for NAGE reached as high as $4.4 million in Q3 2025 and fell as low as -$2.8 million in Q1 2023.
• Historically, Change in Inventory has averaged $635235.3 across 5 years, with a median of $446000.0 in 2022.
• Across the five-year window, Change in Inventory soared 656.41% in 2023 and slumped 1613.85% in 2024, its largest moves.
• Year by year, Change in Inventory stood at -$959000.0 in 2022, then jumped by 298.23% to $1.9 million in 2023, then sank by 171.12% to -$1.4 million in 2024, then soared by 250.59% to $2.0 million in 2025, then jumped by 75.49% to $3.6 million in 2026.
• Per Business Quant data, the three most recent Change in Inventory figures were $3.6 million in Q1 2026, $2.0 million in Q4 2025, and $4.4 million in Q3 2025.